Safety of guselkumab and ustekinumab treatment in patients with moderate-to-severe plaque psoriasis combined with latent tuberculosis or inactive hepatitis B virus infection: A retrospective multicenter observational study

The supplemental material of this article, which includes 3 figures (1.Patient Flowcharts and Follow-up Data Treated with Guselkumab 2.Patient Flowcharts and Follow-up Data Treated with Guselkumab 3.The certificate of english language editing) and 1 table (Hepatitis B screening outcomes at week 0 and 52 of patients combined with inactive HBV infection at baseline).